1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired pneumonia, with regards to early clinical response at 96 hours post first dose. 2. Patients who received lefamulin reported more diarrhea and nausea than those who received moxifloxacin. Evidence Rating Level: 1 (Excellent) #Moxifloxacin #pneumonia #CAP ©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc.
